分子分析对乳腺癌治疗管理的影响
Flavia Ultimescu1,2, Ariana Hudita3,4, Daniela Elena Popa5
1OncoTeam Diagnostic S.A., 010719 Bucharest, Romania.
Journal of clinical medicine
|September 14, 2024
概括
使用下一代测序和液体活检进行分子分析,通过识别亚型和生物标志物来增强乳腺癌 (BC) 治疗. 这种个性化的方法通过定制治疗来改善管理来改善患者的治疗结果.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 生物标志物 生物标志物
背景情况:
- 乳腺癌 (BC) 是全球癌症死亡的主要原因.
- 结核病表现出显著的异质性,需要个性化治疗策略.
- 由于患者和瘤的特征不同,目前的管理往往缺乏准确性.
研究的目的:
- 审查分子分析对乳腺癌治疗管理的影响.
- 为突出下一代测序 (NGS) 和BC.的液体活检的进展.
- 讨论分子数据与临床信息的整合,以实现个性化治疗.
主要方法:
- 专注于下一代测序 (NGS) 来识别分子亚型.
- 重点是液体活检,包括循环瘤细胞 (CTC),循环瘤DNA (ctDNA) 和瘤培养血小板 (TEP).
- 将分子分析数据与临床和病理信息相结合.
主要成果:
- NGS和液体活检可以精确识别BC分子亚型.
- 检测血基生物标志物 (CTC,ctDNA,TEP) 有助于进行非侵入性监测.
- 基于分子形状的个性化治疗策略显示出更好的疗效.
结论:
- 分子造型通过精确的预后和治疗干预来彻底改变乳腺癌的管理.
- 在BC的个性化医疗正在推进,由基因组技术驱动.
- 进一步的研究和实施对于在BC护理中广泛采用分子分析至关重要.
更多相关视频
07:59Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
Published on: September 8, 2023
1.0K
13:24Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
Published on: April 11, 2016
11.8K
相关概念视频
Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
Combination Therapies and Personalized Medicine
4.9K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
